ALKERMES | ALKS - 现金及等价物

金融业

USD

USD 4.39B

现金及等价物

USD 511.53M

USD 120.7M

USD 1.52B

USD 662.09M

USD 1.58B

股息收益率

0

USD -65.93M

USD 139.22M

1.8K

EPS每股收益

USD 0

股本和储备

USD 1.81B

USD 375.31M

债务利息支出

USD 25.93M

USD 8.54M

USD 1.48B

USD 7.56B

USD 501K

USD 1.81B

USD -65.93M

普通股股本

USD 167.54M

135.81

USD -61.93M

USD 496.01M

销售和管理费用

USD 196.64M

USD 298.96M

贸易债权人

USD 142.86M

应收帐款人

USD 456.48M

	现金及等价物	更改		日
AbbVie	USD 6.57B		2.82B	2026-06
Acadia Pharmaceuticals	USD 956.47M		105.02M	2026-06
ALKERMES	USD 511.53M		159.98M	2026-06
Amgen	USD 13.99B		1.95B	2026-06
Biogen	USD 1.28B		2.1B	2026-06
BioMarin Pharmaceutical	USD 874M		1.35B	2026-06
Bristol-Myers Squibb	USD 8.72B		852M	2026-06
Coherus Biosciences	USD 82.92M		32.32M	2026-06
Eli Lilly	USD 8.95B		3.67B	2026-06
Gilead Sciences	USD 7.63B		64M	2026-03
Heron Therapeutics	USD 20.72M		5.4M	2026-06
Ionis Pharmaceuticals	USD 350.06M		1.57B	2026-06
J&J	USD 20.42B		1.27B	2026-06
Malin Corporation	EUR 62.1M		26.4M	2024-12
Merck	USD 6.85B		1.52B	2026-06
Minerva Neurosciences	USD 82.3M		70.02M	2025-12
Nektar Therapeutics	USD 149.58M		134.46M	2026-03
Neurocrine Biosciences	USD 332.4M		65.9M	2026-06
Otsuka Holdings	JPY 534.64B		123.53B	2025-12
Pfizer	USD 976M		727M	2026-06
Regeneron Pharmaceuticals	USD 2.46B		506.8M	2026-06
Vertex Pharmaceuticals	USD 7.85B		605.7M	2026-06